Is it possible to scale the Moscow experience of offset contracts? asks trade group

30 April 2018

Pharmaceutical companies in Russia are ready to increase investments in the development of the industry, if the government guarantees the procurement of at least 30% of manufactured goods.

This was discussed at the X Scientific and Practical Conference Government Regulation and Russian Pharmaceutical Industry - 2018: Continuing the dialogue. Manufacturers consider the lack of guaranteed sales of their products as one of the limiting factors of growth.

Moscow, as the general director of the Association the association of the pharmaceutical producers (ARPM) Viktor Dmitriev has noted, was able to create a model that satisfies all stakeholders. “The city was the first to implement the idea of procurement by concluding contracts with mutual investment obligations,” he said.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK